State of Clinical Trial Technology
In 2026, adoption of clinical trial technology is slowing as AI experimentation is taking off.
This tension marks a pivotal moment for the industry: Agentic oversight represents the future of clinical trials, shifting us from reactive monitors to predictive operators who proactively reduce risk, increase efficiency, and accelerate cures for disease.
Ready to learn more about how we can help your business innovate with generative AI?
All fields marked with * are required.
